Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
In last month's issue, we discussed the Vaccine Court's (Office of Special Masters of the U.S. Court of Federal Claims) trio of decisions that found no causative links between childhood vaccinations and the onset of autism and gastrointestinal problems in three children. In all three cases, the claimants sought compensation from the National Vaccine Injury Compensation Program (Vaccine Program) (See 42 U.S.C. ' 300aa-10, et. seq.), which, since 1988, has compensated victims of known or proven vaccination side effects.
We focused on the case of Michelle Cedillo, a child who was reaching all of her developmental milestones until shortly after she received an MMR (measles, mumps, rubella) shot in December 1995. In the week following the inoculation, she developed a high fever and gastrointestinal complaints. She soon lost the ability to do many of the things she had once done, including her speech capabilities. Michelle was diagnosed with autism in July 1997.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
This article explores legal developments over the past year that may impact compliance officer personal liability.